New

Chrome Plugin Live! Redefine the way you read FinTwit šŸš€ Install Now

You have successfully sign out
Loading...
Shape
Kinnate Biopharma Inc.
KNTE
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

125M

Biotechnology

Next Earning date - 07 Nov 2024

125M

Biotechnology

Next Earning date - 07 Nov 2024

2.65USD
Shape-0.01Ā ( -0.38%)
favorite-chart

Relative Strenght

20
favorite-chart

Volume Buzz

478%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

63%

Quote Panel

Shape
Updated September 9, 2024
1W % 1M % 3M % 1Y 38.02 %

Key Metrics

Shape
  • Market Cap

    124.99M


  • Shares Outstanding

    47.17M


  • Share in Float

    22.68M


  • Dividende

    0


  • Earning Date

    07 Nov 2024


  • Price Target

    2.65


  • Average Volume

    367164


  • Beta

    1.34


  • Range

    1.04-7.185


  • Industry

    Biotechnology


  • Website

    https://www.kinnate.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.00x

P/S Ratio

0.78x

P/B Ratio

0.0

Debt/Equity

0.0%

Net Margin

$-2.8

EPS

How KNTE compares to sector?

P/E Ratio

Relative Strength

Shape

KNTE

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape
0

$1.26

Shape-251%

2024-EPS

0

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Piper Sandler

downgrade

Previous: Overweight

2023-09-19

Now: Neutral

Wedbush

downgrade

Previous: Not converted

2023-09-19

Now: Neutral

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

N/A

-0.61
vsĀ -0.40

Q2.22

arrow
arrow

N/A

-0.62
vsĀ -0.49

Q3.22

arrow
arrow

N/A

-0.70
vsĀ -0.57

Q4.22

arrow
arrow

N/A

-0.72
vsĀ -0.60

Q1.23

arrow
arrow

N/A

-0.73
vsĀ -0.61

Q2.23

arrow
arrow

N/A

-0.68
vsĀ -0.62

Q3.23

arrow
arrow

N/A

-0.65
vsĀ -0.70

Q4.23

arrow
arrow

N/A

-0.72
vsĀ -0.72

Q1.24

arrow
arrow

N/A

-0.29
vsĀ -0.73

Q2.24

arrow
arrow

N/A

-0.29
vsĀ -0.68

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.21

arrow
arrow

NA

NAĀ  vsĀ NA

Q4.21

arrow
arrow

NA

NAĀ  vsĀ NA

Q1.22

arrow
arrow

NA

NAĀ  vsĀ NA

Q2.22

arrow
arrow

NA

NAĀ  vsĀ NA

Q3.22

arrow
arrow

NA

NAĀ  vsĀ NA

Q4.22

arrow
arrow

NA

NAĀ  vsĀ NA

Q1.23

arrow
arrow

NA

NAĀ  vsĀ NA

Q2.23

arrow
arrow

NA

NAĀ  vsĀ NA

Q3.23

arrow
arrow

NA

NAĀ  vsĀ NA

Q4.23

arrow
arrow

NA

NAĀ  vsĀ NA

Return on EquityShape

status-upQoQ

Q1.22

arrow
arrow

-9%

-0.09
vsĀ -0.08

Q2.22

arrow
arrow

-10%

-0.10
vsĀ -0.09

Q3.22

arrow
arrow

-12%

-0.12
vsĀ -0.10

Q4.22

arrow
arrow

-13%

-0.13
vsĀ -0.12

Q1.23

arrow
arrow

-14%

-0.14
vsĀ -0.13

Q2.23

arrow
arrow

-16%

-0.16
vsĀ -0.14

Q3.23

arrow
arrow

-18%

-0.18
vsĀ -0.16

Q4.23

arrow
arrow

-11%

-0.11
vsĀ -0.18

Institutionnal OwnershipShape

status-upQoQ

Q2.22

arrow
arrow

74

74
vsĀ 77

-4%

Q3.22

arrow
arrow

84

84
vsĀ 74

14%

Q4.22

arrow
arrow

81

81
vsĀ 84

-4%

Q1.23

arrow
arrow

75

75
vsĀ 81

-7%

Q2.23

arrow
arrow

73

73
vsĀ 75

-3%

Q3.23

arrow
arrow

58

58
vsĀ 73

-21%

Q4.23

arrow
arrow

63

63
vsĀ 58

9%

Q1.24

arrow
arrow

60

60
vsĀ 63

-5%

Earnings Growth

Latest News